glycopyrronium

 

Topic mentions per year

Topic mentions per year

1966-2018
010203019662018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND Most guidelines recommend either a long-acting beta-agonist (LABA) plus an inhaled glucocorticoid or a long-acting… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2015
2015
We aimed to explore whether the acute bronchodilation induced by indacaterol 150 μg and glycopyrronium bromide 50 μg is additive… (More)
Is this relevant?
2014
2014
BACKGROUND Glycopyrronium is a once daily (o.d.) long-acting muscarinic antagonist that is approved for maintenance treatment of… (More)
Is this relevant?
2014
2014
BACKGROUND Addition of a second bronchodilator from a different pharmacological class may benefit patients with moderate-to… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2014
2014
BACKGROUND To further assess the safety profile of the fixed-dose combination of indacaterol and glycopyrronium (QVA149) and its… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND We evaluated the effect of dual, longacting inhaled bronchodilator treatment on exacerbations in patients with severe… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its monocomponents indacaterol and… (More)
Is this relevant?
2006
2006
The evidence for the management of respiratory tract secretions (RTS) in dying patients with antimuscarinic drugs remains… (More)
Is this relevant?
1990
1990
A sensitive radioreceptor assay was used to determine the pharmacokinetics of glycopyrronium 6 micrograms/kg after intramuscular… (More)
Is this relevant?
1990
1990
A sensitive radioreceptor assay was used to determine the pharmacokinetics of glycopyrronium following a single i.m. injection of… (More)
Is this relevant?